COMP <GO>
BAX vs SOLV // EV/EBITDA & P/E VALUATION
Baxter International Inc. (NYSE) VS. Solventum Corporation (NYSE) • 15-METRIC TALLY: BAX 3
— SOLV 9
■ METRIC PARITY
LAST: $23.00 (-2.13%) • MKT CAP: $12.15B
valuation
—
LAST: $81.33 (-2.67%) • MKT CAP: $14.22B
valuation
7.3x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BAX VS. SOLV)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | BAX | SOLV | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 30.10% | 53.50% | -23.40 | SOLV | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -2.40% | 18.70% | -21.10 | SOLV | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | 7.3x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 2.79% | -0.07% | +2.86 | BAX | /fcf-yield <GO> |
| Operating Margin | -2.70% | 26.20% | -28.90 | SOLV | /operating-margins <GO> |
| Net Profit Margin | -8.50% | 18.70% | -27.20 | SOLV | /net-margins <GO> |
| Revenue Growth (YoY) | 5.70% | 0.90% | +4.80 | BAX | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 2.86% | 0.00% | +2.86 | BAX | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.22 | 2.25 | -0.03 | SOLV | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 6/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 42.3 | 43.4 | -1.10 | SOLV | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.95 | 1.06 | -0.11 | SOLV | /macro-sensitivity <GO> |
| Forward P/E Multiple | 18.0x | 8.5x | +9.50 | SOLV | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $12.15B | $14.22B | -$2.07B | SOLV | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | BAX REV | SOLV REV | BAX GROSS % | SOLV GROSS % | BAX FCF | SOLV FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $11.24B | $8.32B | 30.1% | 53.5% | $339.0M | -$10.0M |
| FY 2024 | $10.64B | $8.25B | 37.5% | 55.6% | $540.4M | $805.0M |
| FY 2023 | $10.36B | $8.20B | — | — | $1.26B | $1.55B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BAX // BETA 0.95
SOLV // BETA 1.06